BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 33651348)

  • 1. Urinary Cell-Free DNA Integrity Analysis.
    Casadio V; Salvi S
    Methods Mol Biol; 2021; 2292():17-22. PubMed ID: 33651348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary Cell-Free DNA: Potential and Applications.
    Salvi S; Casadio V
    Methods Mol Biol; 2019; 1909():201-209. PubMed ID: 30580433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutational Analysis in Urinary Cell-Free DNA: KRAS in Colorectal Cancer.
    Molinari C; Chiadini E
    Methods Mol Biol; 2021; 2292():23-33. PubMed ID: 33651349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary Cell-Free DNA: Isolation, Quantification, and Quality Assessment.
    Casadio V; Salvi S
    Methods Mol Biol; 2019; 1909():211-221. PubMed ID: 30580434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of Copy Number Variation in Urine: c-Myc Evaluation Using a Real-Time PCR Approach.
    Casadio V; Martignano F; Gunelli R; Salvi S
    Methods Mol Biol; 2021; 2292():49-56. PubMed ID: 33651351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative RNA Analysis from Urine Using Real Time PCR.
    Mengual L; Olivan M
    Methods Mol Biol; 2018; 1655():227-237. PubMed ID: 28889389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary Biomarkers in Tumors: An Overview.
    Cimmino I; Bravaccini S; Cerchione C
    Methods Mol Biol; 2021; 2292():3-15. PubMed ID: 33651347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary Nucleic Acid in Tumor: Bioinformatics Approaches.
    Angeli D
    Methods Mol Biol; 2021; 2292():95-104. PubMed ID: 33651354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New method to preserve the original proportion and integrity of urinary cell-free DNA.
    Li P; Ning J; Luo X; Du H; Zhang Q; Zhou G; Du Q; Ou Z; Wang L; Wang Y
    J Clin Lab Anal; 2019 Feb; 33(2):e22668. PubMed ID: 30175467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutation-Enrichment Next-Generation Sequencing for Quantitative Detection of
    Fujii T; Barzi A; Sartore-Bianchi A; Cassingena A; Siravegna G; Karp DD; Piha-Paul SA; Subbiah V; Tsimberidou AM; Huang HJ; Veronese S; Di Nicolantonio F; Pingle S; Vibat CRT; Hancock S; Berz D; Melnikova VO; Erlander MG; Luthra R; Kopetz ES; Meric-Bernstam F; Siena S; Lenz HJ; Bardelli A; Janku F
    Clin Cancer Res; 2017 Jul; 23(14):3657-3666. PubMed ID: 28096270
    [No Abstract]   [Full Text] [Related]  

  • 11. Cell-Free DNA Integrity Analysis in Urine Samples.
    Casadio V; Salvi S; Martignano F; Gunelli R; Ravaioli S; Calistri D
    J Vis Exp; 2017 Jan; (119):. PubMed ID: 28117781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell-Free DNA Integrity: Applications.
    Ravaioli S
    Methods Mol Biol; 2019; 1909():77-83. PubMed ID: 30580423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ultrasensitive hybridization capture: Reliable detection of <1 copy/mL short cell-free DNA from large-volume urine samples.
    Oreskovic A; Lutz BR
    PLoS One; 2021; 16(2):e0247851. PubMed ID: 33635932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of TERT promoter mutations in urinary cell-free DNA and sediment DNA for detection of bladder cancer.
    Stasik S; Salomo K; Heberling U; Froehner M; Sommer U; Baretton GB; Ehninger G; Wirth MP; Thiede C; Fuessel S
    Clin Biochem; 2019 Feb; 64():60-63. PubMed ID: 30528938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging Utility of Urinary Cell-free Nucleic Acid Biomarkers for Prostate, Bladder, and Renal Cancers.
    Lin SY; Linehan JA; Wilson TG; Hoon DSB
    Eur Urol Focus; 2017 Apr; 3(2-3):265-272. PubMed ID: 28753876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Telomerase Activity Analysis In Urine Sediment for Bladder Cancer.
    Casadio V; Bravaccini S
    Methods Mol Biol; 2021; 2292():133-141. PubMed ID: 33651358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The art of obtaining a high yield of cell-free DNA from urine.
    Augustus E; Van Casteren K; Sorber L; van Dam P; Roeyen G; Peeters M; Vorsters A; Wouters A; Raskin J; Rolfo C; Zwaenepoel K; Pauwels P
    PLoS One; 2020; 15(4):e0231058. PubMed ID: 32251424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantification of MicroRNAs in Urine-Derived Specimens.
    Fuessel S; Lohse-Fischer A; Vu Van D; Salomo K; Erdmann K; Wirth MP
    Methods Mol Biol; 2018; 1655():201-226. PubMed ID: 28889388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urine-Based Liquid Biopsy for Nonurological Cancers.
    Jain S; Lin SY; Song W; Su YH
    Genet Test Mol Biomarkers; 2019 Apr; 23(4):277-283. PubMed ID: 30986103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a multivariable risk model integrating urinary cell DNA methylation and cell-free RNA data for the detection of significant prostate cancer.
    Connell SP; O'Reilly E; Tuzova A; Webb M; Hurst R; Mills R; Zhao F; Bapat B; Cooper CS; Perry AS; Clark J; Brewer DS
    Prostate; 2020 May; 80(7):547-558. PubMed ID: 32153047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.